<DOC>
	<DOC>NCT01243853</DOC>
	<brief_summary>The purpose of this study is to determine whether alpha-galactosidase enzyme is affective in alleviating the symptoms of irritable bowel syndrome (IBS).</brief_summary>
	<brief_title>Alpha-galactosidase Enzyme and Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Clinical diagnosis of IBS according to Rome III criteria, additionally abdominal distension or flatulence the most disturbing symptom Age 1865 years Colonoscopy conducted within the previous 5 years, finding macroscopically and histologically normal Organic GI disease. Treated (min. 1 year) coeliac disease patients, and subjects with known and treated lactose intolerance are allowed to participate Malignancy Significant gastrointestinal surgery Clinically significant aberrancies in the screeningphase laboratory analyses Changes in regular medication during the previous 4 weeks Pregnancy or breast feeding Other disease or state that based on the investigator's evaluation complicates the conduction of the intervention, i.e. alcoholism, dementia Hereditary galactosemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>